BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
29/04/2021 - 5 minutes
Innate Pharma
How Immuno-Oncology Contributes to the Fight Against Covid-19
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for…
06/07/2020 - 7 minutes
Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund
Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage…
17/10/2019 - 2 minutes
Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer
The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund…
17/10/2019 - 2 minutes
Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold
A combination cancer immunotherapy from French biotech Innate Pharma was twice as effective at treating…
22/10/2018 - 2 minutes
Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic
Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint…
30/01/2018 - 3 minutes
Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017
As 2016 was a tough year for biotech, 2017 was under pressure to turn things…
12/12/2017 - 7 minutes
French Biotech Announces Positive Phase I Results in T-cell Lymphoma
Innate Pharma has released the safety and efficacy results of a Phase I trial testing…
15/06/2017 - 2 minutes
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
Novo Nordisk has handed over its anti-cancer antibody to Innate Pharma in a new deal…
06/06/2017 - 2 minutes
How is Biotech Transforming Pharma’s R&D Model?
Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances…
06/04/2017 - 4 minutes
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for…
13/02/2017 - 2 minutes
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
Innate Pharma's checkpoint inhibitor candidate lirilumab missed its primary endpoint in a Phase II trial,…
06/02/2017 - 2 minutes
